EC Number |
Inhibitors |
Structure |
---|
6.3.4.14 | 2-amino-N,N-dibenzyl-1,3-oxazole-5-carboxamide |
minimal inhibitory concentration above 64 microg per ml for wild-type, 16 microg per ml for mutant with targeted knock-out of efflux pump tolC and imp gene disruption |
|
6.3.4.14 | 2-amino-N,N-dibenzyl-1,3-oxazole-5-carboxamide |
minimal inhibitory concentration above 64 microg per ml for wild-type, 4 microg per ml for mutant with targeted knock-out of efflux pump acrA |
|
6.3.4.14 | 2-amino-N,N-dibenzyl-1,3-oxazole-5-carboxamide |
minimal inhibitory concentration 8 microg per ml for wild-type, 4 microg per ml for mutant with targeted knock-out of efflux pump acrA |
|
6.3.4.14 | 2-amino-N-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-N-(2-methylbenzyl)-1,3-oxazole-5-carboxamide |
minimal inhibitory concentration above 64 microg per ml for wild-type, 8 microg per ml for mutant with targeted knock-out of efflux pump tolC and imp gene disruption |
|
6.3.4.14 | 2-amino-N-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-N-(2-methylbenzyl)-1,3-oxazole-5-carboxamide |
minimal inhibitory concentration above 64 microg per ml for wild-type, 4 microg per ml for mutant with targeted knock-out of efflux pump acrA |
|
6.3.4.14 | 2-amino-N-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-N-(2-methylbenzyl)-1,3-oxazole-5-carboxamide |
minimal inhibitory concentration 16 microg per ml for wild-type, 4 microg per ml for mutant with targeted knock-out of efflux pump acrA |
|
6.3.4.14 | 2-Pyridyl disulfide |
- |
|
6.3.4.14 | 6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine |
minimal inhibitory concentration 16 microg per ml for wild-type, 0.125 microg per ml for mutant with targeted knock-out of efflux pump tolC and imp gene disruption |
|
6.3.4.14 | 6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine |
minimal inhibitory concentration 0.125 microg per ml for wild-type, 0.125 microg per ml for mutant with targeted knock-out of efflux pump acrA |
|
6.3.4.14 | 6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine |
minimal inhibitory concentration 1 microg per ml for wild-type, 0.5 microg per ml for mutant with targeted knock-out of efflux pump acrA |
|